Literature DB >> 27790303

Salvage radiation therapy 11 years after a radical prostatectomy.

Valérie Hogues1, Carole Lambert2, Michael McCormack3.   

Abstract

We present a patient with a high prostate-specific antigen (PSA) value, who was successfully treated with salvage radiation therapy (RT) 11 years after a radical prostatectomy (RP).

Entities:  

Year:  2016        PMID： 27790303      PMCID： PMC5065411          DOI： 10.5489/cuaj.3400

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  8 in total

1.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist.

Authors:  W C Allsbrook; K A Mangold; M H Johnson; R B Lane; C G Lane; J I Epstein
Journal:  Hum Pathol       Date:  2001-01       Impact factor: 3.466

Review 2.  Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.

Authors:  Matthew N Simmons; Andrew J Stephenson; Eric A Klein
Journal:  Eur Urol       Date:  2007-01-12       Impact factor: 20.096

Review 3.  Gleason grading and prognostic factors in carcinoma of the prostate.

Authors:  Peter A Humphrey
Journal:  Mod Pathol       Date:  2004-03       Impact factor: 7.842

4.  Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.

Authors:  Ian M Thompson; Richard K Valicenti; Peter Albertsen; Brian J Davis; S Larry Goldenberg; Carol Hahn; Eric Klein; Jeff Michalski; Mack Roach; Oliver Sartor; J Stuart Wolf; Martha M Faraday
Journal:  J Urol       Date:  2013-05-21       Impact factor: 7.450

5.  Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

Authors:  Misop Han; Alan W Partin; Marianna Zahurak; Steven Piantadosi; Johnathan I Epstein; Patrick C Walsh
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

6.  Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Authors:  Andrew J Stephenson; Peter T Scardino; Michael W Kattan; Thomas M Pisansky; Kevin M Slawin; Eric A Klein; Mitchell S Anscher; Jeff M Michalski; Howard M Sandler; Daniel W Lin; Jeffrey D Forman; Michael J Zelefsky; Larry L Kestin; Claus G Roehrborn; Charles N Catton; Theodore L DeWeese; Stanley L Liauw; Richard K Valicenti; Deborah A Kuban; Alan Pollack
Journal:  J Clin Oncol       Date:  2007-05-20       Impact factor: 44.544

Review 7.  Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature.

Authors:  Sanoj Punnen; Matthew R Cooperberg; Anthony V D'Amico; Pierre I Karakiewicz; Judd W Moul; Howard I Scher; Thorsten Schlomm; Stephen J Freedland
Journal:  Eur Urol       Date:  2013-05-16       Impact factor: 20.096

Review 8.  The timing of salvage radiotherapy after radical prostatectomy: a systematic review.

Authors:  Christopher R King
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-07-14       Impact factor: 7.038
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.